Clinical Trials Logo
  1. Home
  2. Oral Contraceptive
  3. NCT00972439

Oral Contraceptive (OC) Progestin Dose and Breast Proliferation

Oral Contraceptive Clinical Trial

Official title:
Evaluating the Effect of Oral Contraceptive Progestin Dose on Breast Epithelial Cell Proliferation

Clinical Trial Summary

The purpose of this research study is to gain a better understanding of the changes that may occur in the breast when a woman uses an oral contraceptive (birth control pill). Some research indicates that women who use birth control pills with lower amounts of progestin (a hormone in the birth control pill) may have lower breast cell growth than women who use birth control pills with a higher amount of progestin; this research will examine that in detail.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00972439
Study type Interventional
Source University of Southern California
Contact
Status Completed
Phase N/A
Start date August 2007
Completion date November 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT01388491 - A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women Phase 2
Completed NCT01252186 - A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women Phase 2
Not yet recruiting NCT06426459 - Social Media Usage in Adolescent Girls
Recruiting NCT02398903 - Evaluation of Hormonal Contraceptive Treatments in Obese Women
Completed NCT00302666 - Bleeding Pattern Study Phase 3
Completed NCT00739622 - TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women. Phase 1
Completed NCT01291004 - A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives Phase 1
Recruiting NCT01318005 - Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation N/A
Recruiting NCT02021097 - Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception Phase 3
Completed NCT00778609 - Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache Phase 3
Completed NCT01076582 - Comparative Trial in Hormone Withdrawal Associated Symptoms Phase 3
Completed NCT00471991 - Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition Phase 2
Completed NCT00248963 - Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception Phase 3